Vitamin D and androgen receptor-targeted therapy successfully reduced growth and induced death of cancerous cells in a cell culture model of triple-negative breast cancer.
The 2016 consensus statement from the International Association for the Study of Lung Cancer (IASLC) describes how to best manage EGFR-mutation-positive NSCLC.
The National Cancer Moonshot needs to target proteins that are driving cancer rather than focusing only on genomics, a new paper suggests.
Radiation therapy delivered to the critical vessels surrounding the prostate can result in erectile dysfunction and bladder and renal irritation. Vessel-sparing radiation and an improved understanding of the anatomy of the prostate can reduce these effects.
Training Patients With Breast Cancer to Achieve Prolonged Breath Holds Could Improve Targeted Radiotherapy
Patients with breast cancer can be trained to achieve a breath hold lasting more than 5 minutes, allowing for targeted administration of radiotherapy with a single dose per daily session that can minimize damage to surrounding tissues.
A new drug candidate reduced the growth of tumors in a mouse model of triple negative breast cancer (TNBC) by targeting the RNA, or expression, of a gene only expressed in the diseased cells.
To improve patient comfort during full-body skin cancer screenings, dermatologists should respect patients' preferences for the gender of the examining clinician and for how the genital area is examined.
Including Quality Measures In Treatment Regimens Increases Survival in Stage IIIA Non-Small Cell Lung Cancer
When more quality measures are incorporated into patient care, survival rates for patients with stage IIIA non-small cell lung cancer (NSCLC) increase, but only 13% of eligible patients actually receive all 4 recommended quality measures.
New research results favor testing for prostate specific antigen (PSA) levels for detection of prostate cancer. PSA tests can reduce the number of fatal cases of prostate cancer by detecting disease early.
Genetic Biomarker Predictive of Peripheral Neuropathy in Patients Receiving Docetaxel for Prostate Cancer
Docetaxel-induced neuropathy may be predicted by single nucleotide polymorphisms in VAC14.
- Herbal Remedies May Be an Overlooked Global Health Hazard
- Barriers to Understanding Pancreatic Cancer Can Be Overcome With Improvements to Online Health Information
- New Research Questions Recommendations Regarding PSA Tests for Prostate Cancer Screening
- A Protein Could Predict the Response to Immunotherapy in Metastatic Melanoma
- Specific Lifestyle Factors Can Significantly Affect Cancer Mortality
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Initiating Palliative Care in the Emergency Department
- Implementing a Distress Screening Process for Cancer Patients
- Socioeconomic Benefits of Marriage Improve Survival Among Married Patients
- Delaying Radiation Therapy for Women With Early Stage Breast Cancer Increased Risk of Recurrence
- Vitamin D and Androgen Receptor-Targeted Therapy Are Effective in Triple-Negative Breast Cancer
- Consensus Statement Guides Optimal Management of EGFR-Mutation-Positive NSCLC
- Including Proteomics Is Key to Achieving Goals of National Cancer Moonshot
- Violence in Health Care Workplaces: "Underreported, Tolerated, and Largely Ignored"
- Vessel-Sparing Radiation Successfully Treats Prostate Cancer, Maintains Quality of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|